FR Appelbaum

15.8k total citations · 1 hit paper
189 papers, 12.4k citations indexed

About

FR Appelbaum is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, FR Appelbaum has authored 189 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Hematology, 57 papers in Oncology and 46 papers in Genetics. Recurrent topics in FR Appelbaum's work include Hematopoietic Stem Cell Transplantation (137 papers), Mesenchymal stem cell research (37 papers) and Acute Myeloid Leukemia Research (33 papers). FR Appelbaum is often cited by papers focused on Hematopoietic Stem Cell Transplantation (137 papers), Mesenchymal stem cell research (37 papers) and Acute Myeloid Leukemia Research (33 papers). FR Appelbaum collaborates with scholars based in United States, South Africa and Australia. FR Appelbaum's co-authors include Rainer Storb, CD Buckner, Claudio Anasetti, Jack W. Singer, H. Joachim Deeg, K Doney, JE Sanders, Thomas Ed, Clift Ra and KM Sullivan and has published in prestigious journals such as Blood, Stem Cells and Clinical Pharmacology & Therapeutics.

In The Last Decade

FR Appelbaum

186 papers receiving 11.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment

1991 456 citations FR Appelbaum, GB McDonald et al. Blood profile →

Peers

Countries citing papers authored by FR Appelbaum

Since Specialization

Citations

This map shows the geographic impact of FR Appelbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by FR Appelbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites FR Appelbaum more than expected).

Fields of papers citing papers by FR Appelbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by FR Appelbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by FR Appelbaum. The network helps show where FR Appelbaum may publish in the future.

Co-authorship network of co-authors of FR Appelbaum

This figure shows the co-authorship network connecting the top 25 collaborators of FR Appelbaum. A scholar is included among the top collaborators of FR Appelbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with FR Appelbaum. FR Appelbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Personalized Dosing of Cyclophosphamide in the Total Body Irradiation–Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy 2009 ·Clinical Pharmacology & Therapeutics ·Jeannine S. McCune, Ami Batchelder, (unknown), Robert P. Witherspoon, FR Appelbaum, Brian Phillips, P. Vicini, (unknown), GB McDonald	58
2	Bone Marrow Transplantation for Leukaemia – Current Status and Strategies for Improvement 2004 ·Annals of the Academy of Medicine Singapore ·FR Appelbaum	0
3	Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation 2002 ·Bone Marrow Transplantation ·Jeannine S. McCune, Ted Gooley, (unknown), (unknown), (unknown), FR Appelbaum, Claudio Anasetti, Linda J. Risler, (unknown), (unknown)	96
4	The use of radioimmunoconjugates in stem cell transplantation 2002 ·Bone Marrow Transplantation ·(unknown), (unknown), FR Appelbaum, (unknown), Oliver W. Press	30
5	Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin) 2002 ·Leukemia ·Richard A. Larson, M. A. Boogaerts, Elihu H. Estey, Chatchada Karanes, (unknown), Eric L. Sievers, Philippe Mineur, J M Bennett, M. S. Berger, (unknown), Mihaela Munteanu, (unknown), Jacques J. M. van Dongen, (unknown), FR Appelbaum, (unknown)	168
6	Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia 2002 ·Bone Marrow Transplantation ·KC Doney, Thomas R. Chauncey, FR Appelbaum, (unknown)	66
7	Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older 2001 ·Bone Marrow Transplantation ·Ajay K. Gopal, (unknown), (unknown), DG Maloney, Jack W. Singer, (unknown), FR Appelbaum, Oliver W. Press	50
8	Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience 2000 ·Bone Marrow Transplantation ·Jorge Sierra, Barry E. Storer, JA Hansen, Martin Pj, EW Petersdorf, Ann E. Woolfrey, Dana C. Matthews, JE Sanders, Rainer Storb, FR Appelbaum, Claudio Anasetti	159
9	Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor 2000 ·Bone Marrow Transplantation ·(unknown), K Lilleby, Ignazio Majolino, Rainer Storb, FR Appelbaum, (unknown), Jack W. Singer	141
10	Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities 2000 ·Bone Marrow Transplantation ·T Furlong, Rainer Storb, Claudio Anasetti, FR Appelbaum, H. Joachim Deeg, K Doney, Paul J. Martin, Keith M. Sullivan, RP Witherspoon, (unknown)	41
11	High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer 1998 ·Bone Marrow Transplantation ·(unknown), Taner Demirer, Scott D. Rowley, CD Buckner, Gary Goodman, Richard T. Maziarz, J Klarnet, (unknown), (unknown), R. V. McCloskey, Robert H. Gersh, Rimma Goldberg, W. Garrett Nichols, Alice K. Jacobs, P L Weiden, Paul G. Montgomery, Saul E. Rivkin, FR Appelbaum, Jack W. Singer	25
12	High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer 1997 ·Bone Marrow Transplantation ·Jack W. Singer, K Schiffman, Leona Holmberg, FR Appelbaum, Richard T. Maziarz, Paul G. Montgomery, Erin D. Ellis, Saul E. Rivkin, P L Weiden, K Lilleby, Scott D. Rowley, Stephen H. Petersdorf, (unknown), W. Garrett Nichols, Andrew Hertler, Robert McCroskey, CH Weaver, CD Buckner	26
13	RELATIONSHIP OF SERUM CYTOKINES (TNF-ALPHA, IL-1-BETA, IFN-GAMMA AND INFLAMMATION MARKERS (NEOPTERIN, BETA-2-MICROGLOBULIN, C-REACTIVE PROTEIN) TO TRANSPLANT-RELATED COMPLICATIONS AND IMMUNOGLOBULIN PROPHYLAXIS FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION 1994 ·Ghent University Academic Bibliography (Ghent University) ·KM Sullivan, Fritz Offner, Manfred Herold, Masaru Mori, Christian G. Huber, D Niederwieser, FR Appelbaum, R Storb	1
14	Phase I/II trial of recombinant human granulocyte-macrophage colony- stimulating factor following allogeneic bone marrow transplantation 1991 ·Blood ·John Nemunaitis, CD Buckner, FR Appelbaum, (unknown), Motomi Mori, JA Bianco, Charles B. Epstein, (unknown), J A Hansen, Rainer Storb	70
15	Antibody-radionuclide conjugates as part of a myeloablative preparative regimen for marrow transplantation 1989 ·Blood ·FR Appelbaum, (unknown), Brenda M. Sandmaier, C Badger, Friedrich Schuening, (unknown), R Storb	24
16	Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an update 1985 ·Blood ·JE Sanders, Thomas Ed, CD Buckner, (unknown), PS Stewart, Clift Ra, (unknown), Jack W. Singer, (unknown), FR Appelbaum	3
17	Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an update 1985 ·Blood ·JE Sanders, Thomas Ed, CD Buckner, Nancy Flournoy, PS Stewart, Clift Ra, Lawrence G. Lum, Jack W. Singer, Rainer Storb, FR Appelbaum	60
18	Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse 1983 ·Blood ·FR Appelbaum, Clift Ra, CD Buckner, Patricia Stewart, R Storb, KM Sullivan, Thomas Ed	105
19	Result of attempted hematopoietic reconstitution using isologous, peripheral blood mononuclear cells: a case report 1980 ·Blood ·(unknown), Daniel Glaubiger, FR Appelbaum, AB Deisseroth	79
20	Migration of transfused granulocytes in leukopenic dogs 1977 ·Blood ·FR Appelbaum, (unknown), (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact